BIOS Capital Management, LP
FORT WORTH, TX · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$34.2M2026 Q3
Positions6
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%
What Changed This Quarter?
Biggest trim: LTRN -5.4% in shares
Top Holdings
IRD
Opus Genetics
52.2%
ACTU
Actuate Therapeutics
22.9%
CGTX
Cognition Therapeutics
16.9%
RNTX
Rein Therapeutics
7.0%
LTRN
Lantern Pharma
0.7%
INAB
IN8BIO
0.3%
New / Increased
0 new · 0 increased
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.